Intro:
Founded in Boston, USA in 2010, Syd Labs, Inc. is a pioneering recombinant technology company dedicated to delivering high-quality recombinant antibodies for research and production. Guided by the vision “You deserve a better antibody”, we have spent more than a decade redefining the standards of antibody reagents—emphasizing stronger affinity, superior performance, stable lot-to-lot consistency, and faster experimental response. Today, our products and services are trusted worldwide by leading universities, research institutes, and biotechnology and biopharmaceutical companies across North America, Europe, and Asia.

Say yes to recombinant technology — no to animal-derived antibodies!
Features:
1. Animal-free, contamination-free production
o Produced using chemically defined media and CHO cells, eliminating
antibody contamination risks associated with hybridoma-derived mouse
ascites, and FBS for cell culturing of hybridoma cells.
o Ensures stable, consistent quality without batch-to-batch variability.

2. Unlimited engineering flexibility
o Tailored recombinant platform supports isotype switching, Fc region
modifications, affinity optimization, yield improvement, humanization,
bispecific, protein modular fusion, and conjugation.
o Enables precise customization for diverse research needs.

3. High quality at lower cost
o With equal purity and endotoxin standards, Syd Labs offers prices up to
50% lower than competitors.
o Endotoxin levels can be reduced to as low as 0.05 EU/mg, meeting FDA-
quality thresholds for clinical products, the lowest level currently available
in research-grade antibodies.

Key Products:
Anti-Mouse Antibodies (In Vivo Grade, Recombinant)
Isotype Control Antibodies
Research Grade Biosimilars
Anti-Human Antibodies (In Vivo Grade, Recombinant)
Anti-Mouse Antibodies (For Flow Cytometry, Recombinant)
Anti-Human Antibodies (For Flow Cytometry, Recombinant)
Immunoassay Blockers

Visit site: https://www.sydlabs.com/